Holen Sie sich die Stockscreener-App
6.065
2.80%
0.165
Schlusskurs vom Vortag:
$5.90
Offen:
$6.06
24-Stunden-Volumen:
754
Relative Volume:
0.00
Marktkapitalisierung:
$5.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.77M
KGV:
-0.00461
EPS:
-1316.2474
Netto-Cashflow:
$-14.37M
1W Leistung:
-10.81%
1M Leistung:
+0.58%
6M Leistung:
+4,314%
1J Leistung:
+17.08%
1-Tages-Spanne:
$6.0193
$6.06
1-Wochen-Bereich:
$5.77
$6.4999
52-Wochen-Spanne:
$0.0927
$15.90
Glucotrack Inc Stock (GCTK) Company Profile
Firmenname
Glucotrack Inc
Sektor
Telefon
972 (8) 675-7878
Adresse
301 RT 17 NORTH, RUTHERFORD
Vergleichen Sie GCTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
6.0193 | 5.45M | 0 | -26.77M | -14.37M | -1,316.25 |
|
ISRG
Intuitive Surgical Inc
|
575.33 | 201.58B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.33 | 55.30B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.40 | 38.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
255.28 | 36.71B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
278.51 | 20.27B | 2.96B | 487.70M | 344.00M | 6.6758 |
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
How supply chain issues affect GlucoTrack Inc. stockMarket Weekly Review & Verified Chart Pattern Trade Signals - Newser
Why GlucoTrack Inc. stock remains on watchlistsJuly 2025 Outlook & Daily Chart Pattern Signals - Newser
GlucoTrack (NASDAQ:GCTK) Stock Price Down 7.5% – Here’s What Happened - Defense World
Head to Head Review: biote (NASDAQ:BTMD) vs. GlucoTrack (NASDAQ:GCTK) - Defense World
GlucoTrack Inc Stock Analysis and ForecastCup and Handle Formations & Superior Capital Growth - earlytimes.in
ASHFORD HOSPITALITY TRUST, INC. (AHT) - MSN
Glucotrack Reports Q3 2025 Results and Strategic Progress - MSN
What analysts say about GlucoTrack Inc stockMid Cap Growth Trends & Market Crushing Stock Picks - earlytimes.in
GlucoTrack Inc. (GCTK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is GlucoTrack Inc. stock recession proof2025 Big Picture & Long-Term Capital Growth Ideas - newser.com
What analyst consensus says on GlucoTrack Inc. stockDividend Hike & Weekly Consistent Profit Watchlists - newser.com
GCTK SEC FilingsGlucotrack 10-K, 10-Q, 8-K Forms - Stock Titan
Is GlucoTrack Inc. stock gaining market shareWeekly Profit Summary & Consistent Return Investment Signals - newser.com
Can GlucoTrack Inc. stock outperform in 2025 bull market2025 Dividend Review & Community Shared Stock Ideas - newser.com
How GlucoTrack Inc. stock reacts to bond yieldsJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com
How interest rate cuts could boost GlucoTrack Inc. stockQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Can GlucoTrack Inc. stock resist sector downturns2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
Does GlucoTrack Inc. stock trade at a discount to peersDay Trade & Free Weekly Watchlist of Top Performers - newser.com
How GlucoTrack Inc. stock reacts to job market dataPortfolio Gains Report & Consistent Income Trade Ideas - newser.com
Published on: 2025-11-15 02:03:37 - newser.com
Why GlucoTrack Inc. stock could benefit from AI revolutionJuly 2025 Chart Watch & Free Safe Capital Growth Stock Tips - Fundação Cultural do Pará
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights - The Manila Times
GlucoTrack Inc. stock daily chart insightsTrade Performance Summary & Smart Swing Trading Techniques - newser.com
[8-K] Glucotrack, Inc. Reports Material Event | GCTK SEC FilingForm 8-K - Stock Titan
GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Glucotrack, Inc. Quarterly Earnings Report | GCTK SEC FilingForm 10-Q - Stock Titan
Glucotrack (NASDAQ: GCTK) plans IDE submission Spring 2026, $7.9M cash to support trials - Stock Titan
GlucoTrack (NASDAQ:GCTK) and Else Nutrn (OTCMKTS:BABYF) Critical Comparison - Defense World
Finanzdaten der Glucotrack Inc-Aktie (GCTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):